Within the subgroup expressing high FRα, the MIRV cohort experienced longer OS compared to chemotherapy, though this difference did not reach statistical significance.
1
—
—
Within the subgroup expressing high FRα, the MIRV cohort experienced longer OS compared to chemotherapy, though this difference did not reach statistical significance.